Wellell Inc - Asset Resilience Ratio
Wellell Inc (4106) has an Asset Resilience Ratio of 2.43% as of September 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Check how strategically is Wellell Inc's equity deployed to assess the company's strategic physical and investment asset allocation.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio Trend (2002–2024)
This chart shows how Wellell Inc's Asset Resilience Ratio has changed over time. See Wellell Inc balance sheet independence to measure how much of total assets are equity-financed.
Liquid Assets Composition Over Time
This chart breaks down Wellell Inc's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see Wellell Inc (4106) total market value.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | NT$0.00 | 0% |
| Short-term Investments | NT$77.17 Million | 2.43% |
| Total Liquid Assets | NT$77.17 Million | 2.43% |
Asset Resilience Insights
- Limited Liquidity: Wellell Inc maintains only 2.43% of assets in liquid form.
- This low level may indicate efficient asset utilization but could pose risks during economic downturns.
- The company has significant short-term investments, indicating active treasury management.
Wellell Inc Industry Peers by Asset Resilience Ratio
Compare Wellell Inc's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Medacta Group SA
SW:MOVE |
Medical Devices | 0.86% |
|
Double Medical Technology Inc
SHE:002901 |
Medical Devices | 12.59% |
|
Shenzhen New Industries Biomedical
SHE:300832 |
Medical Devices | 9.95% |
|
Jafron Biomedical Co Ltd
SHE:300529 |
Medical Devices | 39.15% |
|
Sinocare Inc
SHE:300298 |
Medical Devices | 3.53% |
|
Xiangyu Medical Co. Ltd. A
SHG:688626 |
Medical Devices | 1.53% |
|
INKON Life Technology Co Ltd
SHE:300143 |
Medical Devices | 5.73% |
|
HOB Biotech Group Corp Ltd
SHG:688656 |
Medical Devices | 2.62% |
Annual Asset Resilience Ratio for Wellell Inc (2002–2024)
The table below shows the annual Asset Resilience Ratio data for Wellell Inc.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2024-12-31 | 4.19% | NT$131.33 Million ≈ $4.14 Million |
NT$3.14 Billion ≈ $98.86 Million |
+0.75pp |
| 2023-12-31 | 3.44% | NT$110.93 Million ≈ $3.49 Million |
NT$3.22 Billion ≈ $101.60 Million |
+0.15pp |
| 2022-12-31 | 3.29% | NT$105.16 Million ≈ $3.31 Million |
NT$3.20 Billion ≈ $100.74 Million |
-0.07pp |
| 2021-12-31 | 3.36% | NT$105.59 Million ≈ $3.33 Million |
NT$3.14 Billion ≈ $98.94 Million |
-1.67pp |
| 2020-12-31 | 5.03% | NT$153.30 Million ≈ $4.83 Million |
NT$3.05 Billion ≈ $95.98 Million |
-7.01pp |
| 2019-12-31 | 12.04% | NT$363.61 Million ≈ $11.46 Million |
NT$3.02 Billion ≈ $95.16 Million |
-4.01pp |
| 2018-12-31 | 16.05% | NT$504.99 Million ≈ $15.91 Million |
NT$3.15 Billion ≈ $99.12 Million |
+9.88pp |
| 2017-12-31 | 6.17% | NT$159.49 Million ≈ $5.02 Million |
NT$2.58 Billion ≈ $81.42 Million |
-0.80pp |
| 2016-12-31 | 6.97% | NT$180.59 Million ≈ $5.69 Million |
NT$2.59 Billion ≈ $81.63 Million |
-0.65pp |
| 2015-12-31 | 7.62% | NT$190.51 Million ≈ $6.00 Million |
NT$2.50 Billion ≈ $78.79 Million |
-2.68pp |
| 2014-12-31 | 10.30% | NT$259.44 Million ≈ $8.17 Million |
NT$2.52 Billion ≈ $79.35 Million |
+1.26pp |
| 2013-12-31 | 9.04% | NT$219.61 Million ≈ $6.92 Million |
NT$2.43 Billion ≈ $76.54 Million |
+1.69pp |
| 2012-12-31 | 7.35% | NT$158.44 Million ≈ $4.99 Million |
NT$2.15 Billion ≈ $67.89 Million |
+7.34pp |
| 2011-12-31 | 0.01% | NT$221.00K ≈ $6.96K |
NT$1.95 Billion ≈ $61.37 Million |
-4.37pp |
| 2010-12-31 | 4.39% | NT$71.09 Million ≈ $2.24 Million |
NT$1.62 Billion ≈ $51.07 Million |
+0.75pp |
| 2009-12-31 | 3.64% | NT$60.02 Million ≈ $1.89 Million |
NT$1.65 Billion ≈ $51.98 Million |
-1.78pp |
| 2008-12-31 | 5.42% | NT$95.43 Million ≈ $3.01 Million |
NT$1.76 Billion ≈ $55.48 Million |
+0.00pp |
| 2007-12-31 | 5.41% | NT$87.38 Million ≈ $2.75 Million |
NT$1.61 Billion ≈ $50.84 Million |
-1.95pp |
| 2005-12-31 | 7.36% | NT$100.43 Million ≈ $3.16 Million |
NT$1.36 Billion ≈ $42.99 Million |
-4.50pp |
| 2004-12-31 | 11.86% | NT$144.07 Million ≈ $4.54 Million |
NT$1.22 Billion ≈ $38.28 Million |
-0.50pp |
| 2003-12-31 | 12.36% | NT$148.08 Million ≈ $4.67 Million |
NT$1.20 Billion ≈ $37.76 Million |
-0.89pp |
| 2002-12-31 | 13.24% | NT$80.00 Million ≈ $2.52 Million |
NT$604.01 Million ≈ $19.03 Million |
-- |
About Wellell Inc
Wellell Inc. engages in the manufacture and sale of medical supplies in Europe, the United States, Asia, and internationally. The company offers support surface systems, respiratory therapy devices, and other products. It also provides pressure relief mattress; sleep apnea such as auto-adjusting pressure; sleepwell; compression therapy; and pressure relief seating products. In addition, the compa… Read more